WallStSmart

Nebius Group N.V. (NBIS)vsWaters Corporation (WAT)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Waters Corporation generates 329% more annual revenue ($3.77B vs $877.90M). NBIS leads profitability with a 93.1% profit margin vs 11.9%. NBIS appears more attractively valued with a PEG of 0.63. WAT earns a higher WallStSmart Score of 53/100 (C-).

NBIS

Buy

53

out of 100

Grade: C-

Growth: 8.0Profit: 5.0Value: 6.7Quality: 5.5
Piotroski: 5/9Altman Z: 0.92

WAT

Buy

53

out of 100

Grade: C-

Growth: 5.3Profit: 5.5Value: 3.3Quality: 6.8
Piotroski: 4/9Altman Z: 4.92
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

NBISUndervalued (+33.0%)

Margin of Safety

+33.0%

Fair Value

$309.18

Current Price

$221.15

$88.03 discount

UndervaluedFair: $309.18Overvalued
WATSignificantly Overvalued (-62.6%)

Margin of Safety

-62.6%

Fair Value

$202.45

Current Price

$348.07

$145.62 premium

UndervaluedFair: $202.45Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NBIS4 strengths · Avg: 9.3/10
Profit MarginProfitability
93.1%10/10

Keeps 93 of every $100 in revenue as profit

Revenue GrowthGrowth
621.0%10/10

Revenue surging 621.0% year-over-year

Market CapQuality
$52.63B9/10

Large-cap with strong market position

PEG RatioValuation
0.638/10

Growing faster than its price suggests

WAT2 strengths · Avg: 10.0/10
Revenue GrowthGrowth
91.5%10/10

Revenue surging 91.5% year-over-year

Altman Z-ScoreHealth
4.9210/10

Safe zone — low bankruptcy risk

Areas to Watch

NBIS4 concerns · Avg: 3.3/10
Price/BookValuation
12.3x4/10

Trading at 12.3x book value

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Debt/EquityHealth
1.063/10

Elevated debt levels

P/E RatioValuation
80.0x2/10

Premium valuation, high expectations priced in

WAT4 concerns · Avg: 3.3/10
PEG RatioValuation
1.584/10

Expensive relative to growth rate

Price/BookValuation
8.1x4/10

Trading at 8.1x book value

Return on EquityProfitability
5.2%3/10

ROE of 5.2% — below average capital efficiency

P/E RatioValuation
44.3x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : NBIS

The strongest argument for NBIS centers on Profit Margin, Revenue Growth, Market Cap. Profitability is solid with margins at 93.1% and operating margin at -32.1%. Revenue growth of 621.0% demonstrates continued momentum.

Bull Case : WAT

The strongest argument for WAT centers on Revenue Growth, Altman Z-Score. Revenue growth of 91.5% demonstrates continued momentum.

Bear Case : NBIS

The primary concerns for NBIS are Price/Book, EPS Growth, Debt/Equity. A P/E of 80.0x leaves little room for execution misses.

Bear Case : WAT

The primary concerns for WAT are PEG Ratio, Price/Book, Return on Equity. A P/E of 44.3x leaves little room for execution misses.

Key Dynamics to Monitor

NBIS carries more volatility with a beta of 1.24 — expect wider price swings.

NBIS is growing revenue faster at 621.0% — sustainability is the question.

WAT generates stronger free cash flow (-42M), providing more financial flexibility.

Monitor INTERNET CONTENT & INFORMATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NBIS scores higher overall (53/100 vs 53/100), backed by strong 93.1% margins and 621.0% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Nebius Group N.V.

COMMUNICATION SERVICES · INTERNET CONTENT & INFORMATION · USA

Nebius Group N.V. (Ticker: NBIS) is a forward-looking technology company specializing in advanced digital solutions designed to enhance client engagement and streamline operational efficiency across diverse sectors. By harnessing the power of cloud computing, artificial intelligence, and data analytics, Nebius equips businesses to effectively manage the complexities of the digital age. With a strong portfolio of intellectual property and meaningful strategic partnerships, the company is poised to capture significant growth opportunities in the dynamic technology landscape, positioning itself as an appealing investment choice for institutional investors seeking high-growth prospects in tech-driven markets.

Visit Website →

Waters Corporation

HEALTHCARE · DIAGNOSTICS & RESEARCH · USA

Waters Corporation is a publicly traded Analytical Laboratory instrument and software company headquartered in Milford, Massachusetts.

Want to dig deeper into these stocks?